Tanaz R. Ferzandi, MD

Tanaz Ferzandi, MD, joined Keck Medicine of USC as the director of urogynecology and reconstructive pelvic surgery in December 2019. She is the service line chief of obstetrics and gynecology at Keck Hospital of USC.

Her specialties include urinary incontinence (stress incontinence, urge, overflow), pelvic organ prolapse (cystocele, rectocele, uterine prolapse), fecal incontinence, mesh-related complications from prior pelvic surgery, fistulas (rectovaginal, genitourinary), recurrent urinary tract infections, asymptomatic microscopic hematuria, post-obstetrical pelvic floor trauma, menopause-related conditions (vulvar dystrophy, vaginal atrophy) and symptomatic fibroids.

Dr. Ferzandi is also an associate professor of obstetrics and gynecology at the Keck School of Medicine of USC and associate fellowship director for urogynecology and reconstructive pelvic surgery. In 2023, she was elected to serve as the secretary and treasurer of the Keck Hospital Medical Executive Staff, in line to become chief of staff in the upcoming years.

Dr. Ferzandi completed her medical degree and her master’s degree in cell biology at the University of Kansas Medical Center. She then completed her residency in obstetrics and gynecology followed by a three-year fellowship in urogynecology and reconstructive pelvic surgery at Harvard University. Given her interest in health care policy and business, Dr. Ferzandi obtained her master’s degree in business administration from the Heller School for Social Policy and Management at Brandeis University.

Dr. Ferzandi has been an active member of the American Urogynecologic Society (AUGS), serving on the coding committee, the payment reform committee and the finance committee. She served a three-year term as a director-at-large on the board of directors for the organization and was chair of the practice management arm. In January 2023, she was elected vice president of AUGS, currently is president-elect and will serve as its president in 2025. Dr. Ferzandi is also a fellow of the American College of Surgeons (ACS), is active with the advocacy arm of ACS and is an elected member of the ACS Women in Surgery Committee.

Prior to joining Keck Medicine, Dr. Ferzandi was instrumental to the development of the urogynecology division at Tufts Medical Center, where she was elected president of the medical staff while serving on many academic and hospital quality committees. At Keck Medicine, she has taken on several roles in administration to continue to advance the division of urogynecology and align with her principles in quality assurance.

Dr. Ferzandi is an examiner for the American Board of Obstetrics and Gynecology (both the general gynecology and the and subspecialty urogynecology boards). She is passionate about education and training the next generation of gynecologists and urogynecologists and has received numerous teaching awards and accolades for her efforts. She was named a Boston magazine and Castle Connolly “Top Doctor” for several years and among “Top Doctors in 2021” by LA Business Journal. Most recently, she received the prestigious 2024 USC Choi Family Awards for Excellence in Patient-Centered Care, which is awarded to one physician annually in the health system.